SUMMARY The hxc1 mutant was identified by screening an EMS (ethylmethane sulphonate) mutagenized population of Arabidopsis Col-0 plants for an altered hypersensitive response (HR), after spray inoculation with an HR-inducing isolate of Xanthomonas campestris pv. campestris (Xcc) (strain 147). The hxc1 mutant shows a susceptible phenotype several days after initiation of the interaction with the avirulent strain. This macroscopically observed phenotype was confirmed by measurement of in planta bacterial growth and by microscopical analysis. Interestingly, the hxc1 mutation acts very specifically. Hxc1 displays a pathophenotype identical to that observed in the wild-type with several extensively characterized avirulent and virulent bacteria, except in response to Pseudomonas syringae pv. tomato strain DC3000/avrRpm1, for which a partial loss of resistance was observed. Finally, the mutation causes an attenuation of expression of several defence markers regulated through different signalling pathways. Together, these data underline the complexity of this novel defence mutant, and support the hypothesis of a mutation affecting a key component acting during the first steps of the plant defence response leading to resistance to Xcc147 and Pseudomonas syringae pv. tomato containing the avr gene, avrRpm1.

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1364-3703.2004.00245.xDOI Listing

Publication Analysis

Top Keywords

altered hypersensitive
8
hypersensitive response
8
xanthomonas campestris
8
campestris campestris
8
hxc1 displays
8
hxc1 mutant
8
pseudomonas syringae
8
syringae tomato
8
hxc1
5
arabidopsis mutant
4

Similar Publications

Background: Fragile X syndrome (FXS) is a leading known genetic cause of intellectual disability and autism spectrum disorders (ASD)-associated behaviors. A consistent and debilitating phenotype of FXS is auditory hypersensitivity that may lead to delayed language and high anxiety. Consistent with findings in FXS human studies, the mouse model of FXS, the Fmr1 knock out (KO) mouse, shows auditory hypersensitivity and temporal processing deficits.

View Article and Find Full Text PDF

Brain-derived neurotrophic factor (BDNF) and tropomyosin receptor kinase B (TrkB) are known to contribute to both protective and pronociceptive processes. However, their contribution to neuropathic pain after spinal cord injury (SCI) needs further investigation. In a recent study utilizing TrkB mice, it was shown that systemic pharmacogenetic inhibition of TrkB signaling with 1NM-PP1 (1NMP) immediately after SCI delayed the onset of pain hypersensitivity, implicating maladaptive TrkB signaling in pain after SCI.

View Article and Find Full Text PDF

Asthma affects approximately 300 million individuals worldwide and the onset predominantly arises in childhood. Children are exposed to multiple environmental irritants, such as viruses and allergens, that are common triggers for asthma onset, whilst their immune systems are developing in early life. Understanding the impact of allergen exposures on the developing immune system and resulting alterations in lung function in early life will help prevent the onset and progression of allergic asthma in children.

View Article and Find Full Text PDF

Allergic reactions and angioedema are important immunologic conditions in acute care settings. Prior data indicate an association between symptom severity and maximum lysis (ML) in thromboelastometry. We aimed to evaluate the dynamics of ML two hours after admission to the emergency department.

View Article and Find Full Text PDF
Article Synopsis
  • Atopic dermatitis (AD) is a chronic skin condition with a weakened epidermal barrier and altered immune responses, linked to reduced NRF2 activity in affected patients.
  • Genetic and proteomics studies using special mouse models showed that low NRF2 levels lead to increased DNA damage and more senescent skin cells.
  • While temporarily activating NRF2 may offer some protection, excessive or long-term activation can worsen skin issues, highlighting the need for careful management in treating AD patients.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!